← Back to Clinical Trials
Recruiting NCT04144894

NCT04144894 The Biosonographic Index

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04144894
Status Recruiting
Phase
Sponsor University of Alabama at Birmingham
Condition Acute Kidney Injury
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2020-01-15
Primary Completion 2026-10-15

Eligibility & Interventions

Sex All sexes
Min Age 19 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Shear Wave Elastography

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2020-01-15 with a primary completion date of 2026-10-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

In this exploratory study we explore the use of Shear Wave Elastography to differentiate between Acute Kidney Injury after vascular surgery and among the healthy population.

Eligibility Criteria

Inclusion Criteria: * No history of diabetes or hypertension * Estimated Glomerular Filtration Rate \> 60 ml/min/m\^2 * Structurally normal kidney on renal ultrasound * BMI \< 27 kg/m\^2 Exclusion Criteria: * Prisoners directly admitted from a correctional facility * Children \< 19 years or under 50 kg body weight if age is unknown * Patients with end stage renal disease or preexisting glomerular filtration rate less than or equal to 30 mL/min/1.73 m\^2 or need for dialysis * Patients with end stage heart disease on the cardiac transplant list * Patients undergoing procedures without vascular surgery * All transplant patients * Patients on ventricular assist devices * Patients undergoing emergency procedures * Patients with body mass index \> 27kg/m\^2 * Any condition that would impede visualization of the kidneys by ultrasound

Contact & Investigator

Central Contact

Adam B Sturdivant, MPH

✉ Adamsturdivant@uabmc.edu

📞 205-934-4042

Principal Investigator

Ahmed Zaky, MD, MPH

PRINCIPAL INVESTIGATOR

University of Alabama at Birmingham

Frequently Asked Questions

Who can join the NCT04144894 clinical trial?

This trial is open to participants of all sexes, aged 19 Years or older, studying Acute Kidney Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04144894 currently recruiting?

Yes, NCT04144894 is actively recruiting participants. Contact the research team at Adamsturdivant@uabmc.edu for enrollment information.

Where is the NCT04144894 trial being conducted?

This trial is being conducted at Birmingham, United States.

Who is sponsoring the NCT04144894 clinical trial?

NCT04144894 is sponsored by University of Alabama at Birmingham. The principal investigator is Ahmed Zaky, MD, MPH at University of Alabama at Birmingham. The trial plans to enroll 50 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology